These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33461354)

  • 1. Effects of topical prostaglandin drops on angiogenesis in an in ovo chick chorioallantoic membrane model.
    Sabaner MC; Duman R; Vurmaz A; Ertekin T
    Cutan Ocul Toxicol; 2021 Mar; 40(1):54-60. PubMed ID: 33461354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues.
    El Ameen A; Vandermeer G; Khanna RK; Pisella PJ
    Eur J Ophthalmol; 2019 Nov; 29(6):645-653. PubMed ID: 30301370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In ovo leptin administration inhibits chorioallantoic membrane angiogenesis in female chicken embryos through the STAT3-mediated vascular endothelial growth factor (VEGF) pathway.
    Su L; Rao K; Guo F; Li X; Ahmed AA; Ni Y; Grossmann R; Zhao R
    Domest Anim Endocrinol; 2012 Jul; 43(1):26-36. PubMed ID: 22417645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
    Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
    Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs.
    Schwartz GF; Tan J; Kotak S
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):555-61. PubMed ID: 20028264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.
    Eisenberg DL; Toris CB; Camras CB
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S105-15. PubMed ID: 12204706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the efficacy of latanoprost (0.005%), bimatoprost (0.03%), travoprost (0.004%), and timolol (0.5%) in the treatment of primary open angle glaucoma.
    Mishra D; Sinha BP; Kumar MS
    Korean J Ophthalmol; 2014 Oct; 28(5):399-407. PubMed ID: 25276082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost.
    Park J; Cho HK; Moon JI
    Jpn J Ophthalmol; 2011 Jan; 55(1):22-7. PubMed ID: 21331688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of second-generation H1-antihistamine drugs on angiogenesis in
    Duman N; Duman R; Vurmaz A
    Cutan Ocul Toxicol; 2023 Mar; 42(1):8-11. PubMed ID: 36469932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.
    Reardon G; Schwartz GF; Mozaffari E
    Clin Ther; 2003 Apr; 25(4):1172-85. PubMed ID: 12809964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness.
    Zhong Y; Shen X; Yu J; Tan H; Cheng Y
    Cornea; 2011 Aug; 30(8):861-4. PubMed ID: 21499083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.
    Arcieri ES; Santana A; Rocha FN; Guapo GL; Costa VP
    Arch Ophthalmol; 2005 Feb; 123(2):186-92. PubMed ID: 15710814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periorbital Changes associated with Topical Prostaglandins Analogues in a Hispanic Population.
    Rodríguez-Agramonte F; Jiménez JC; Montes JR
    P R Health Sci J; 2017 Dec; 36(4):218-222. PubMed ID: 29220066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Considerations about administration angle of prostaglandin analogs].
    Estacia P; Tognon T
    Arq Bras Oftalmol; 2008; 71(5):684-8. PubMed ID: 19039464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents.
    Whitson JT; Petroll WM
    Adv Ther; 2012 Oct; 29(10):874-88. PubMed ID: 23065664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
    Ota T; Aihara M; Narumiya S; Araie M
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs.
    Inoue K; Shiokawa M; Wakakura M; Tomita G
    J Glaucoma; 2013; 22(8):626-31. PubMed ID: 22936280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
    Gagliuso DJ; Wang RF; Mittag TW; Podos SM
    Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
    Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
    Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.
    Choi HY; Lee JE; Lee JW; Park HJ; Lee JE; Jung JH
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):146-52. PubMed ID: 22107041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.